ArticleBMC bioinformatics2025
SaeGraphDTI: drug-target interaction prediction based on sequence attribute extraction and graph neural network.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAccurately identifying drug-target interactions (DTI) can greatly shorten the drug development cycle and reduce the cost of drug development. In current deep learning-based DTI prediction models, the extraction of drug and target features is a key step to improve model performance. At the same time, drugs and targets form a complex relational network, and leveraging existing network topological relationships can obtain more comprehensive feature representations.
resultsWe propose a DTI prediction model based on sequence attribute extraction and graph neural networks, named SaeGraphDTI. First, sequence feature extractors are applied to extract relevant properties of drug and target sequences. Then, based on similarity relationships, the existing relational network is supplemented, and the graph encoder updates node information based on this network. Finally, the graph decoder calculates the probability of edge existence to predict DTI. Our model was compared with other state-of-the-art methods on four public datasets and achieved the best results in most key metrics.
conclusionThese results demonstrate the excellent capability of this model in predicting potential DTI, providing a valuable tool for drug development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.